Patent · US Active

AAV8 mutant capsids and compositions containing same

US11091776B2 · kind B2 · utility

0Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2017
Grant dateAug 17, 2021
Priority date—
Expiry dateFeb 22, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/6027
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are AAV8 mutant capsids and rAAV comprising the same. In one embodiment, vectors employing the AAV8 mutant capsid show increased transduction in a selected tissue as compared to AAV8.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.